Literature DB >> 26383014

Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population.

Silan Gu1, Yunbo Chen1, Xuewu Zhang2, Haifeng Lu1, Tao Lv1, Ping Shen1, Longxian Lv1, Beiwen Zheng1, Xiawei Jiang1, Lanjuan Li3.   

Abstract

Fecal microbial transplantation provides a high curative rate for recurrent Clostridium difficile infection (CDI). However, limitations associated with FMT drive the need to identify key taxa for selective probiotic therapy for prevention, treatment and cure of human CDI. CDI-associated changes in gut microbiota were investigated in adult patients in the Western countries and among infant population in China. However, there has been no such study involving adult patients in China. Therefore, using high throughput sequencing of the 16S ribosomal RNA V3 region and real-time quantitative polymerase chain reaction, we identified CDI-associated key taxa by comparing the fecal microbiota composition of 15 adult patients with CDI with those of 18 individuals with C. difficile-negative nosocomial diarrhea (CDN) and 25 healthy control subjects. Reduced fecal bacterial diversity and dramatic shifts of intestinal microbial composition in CDI and CDN groups were observed compared with healthy controls. Putative butyrate-producing anaerobic bacteria were significantly depleted whereas endotoxin-producing opportunistic pathogens and lactate-producing phylotypes increased dramatically in patients with CDI compared with healthy controls. Further screening of specific microbes causing diarrheal diseases and resistance against CDI is necessary.
Copyright © 2015 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  16S rRNA gene sequence; Clostridium difficile infection; Intestinal microbiota

Mesh:

Substances:

Year:  2015        PMID: 26383014     DOI: 10.1016/j.micinf.2015.09.008

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  29 in total

Review 1.  Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection.

Authors:  Alyse L Frisbee; William A Petri
Journal:  Trends Mol Med       Date:  2020-02-17       Impact factor: 11.951

Review 2.  Microbiota and pathogen 'pas de deux': setting up and breaking down barriers to intestinal infection.

Authors:  Elizabeth S McKenney; Melissa M Kendall
Journal:  Pathog Dis       Date:  2016-05-31       Impact factor: 3.166

Review 3.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model.

Authors:  Qiaomai Xu; Shumeng Zhang; Jiazheng Quan; Zhengjie Wu; Silan Gu; Yunbo Chen; Beiwen Zheng; Longxian Lv; Lanjuan Li
Journal:  Appl Microbiol Biotechnol       Date:  2022-09-10       Impact factor: 5.560

5.  Characterization of Gut Microbiota in Hospitalized Patients with Clostridioides difficile Infection.

Authors:  Bahareh Vakili; Abolfazl Fateh; Hamid Asadzadeh Aghdaei; Fattah Sotoodehnejadnematalahi; Seyed Davar Siadat
Journal:  Curr Microbiol       Date:  2020-04-15       Impact factor: 2.188

Review 6.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

Review 7.  Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?

Authors:  Jennifer K Spinler; Caná L Ross; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-13       Impact factor: 3.331

Review 8.  Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.

Authors:  Caná L Ross; Jennifer K Spinler; Tor C Savidge
Journal:  Anaerobe       Date:  2016-05-12       Impact factor: 3.331

9.  Evaluating the effect of Clostridium difficile conditioned medium on fecal microbiota community structure.

Authors:  Sabina Horvat; Aleksander Mahnic; Martin Breskvar; Saso Dzeroski; Maja Rupnik
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

10.  Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.

Authors:  William Sangster; John P Hegarty; Kathleen M Schieffer; Justin R Wright; Jada Hackman; David R Toole; Regina Lamendella; David B Stewart
Journal:  Front Microbiol       Date:  2016-05-25       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.